Cost-effectiveness of mirtazapine for agitated behaviors in dementia: Findings from a randomized controlled trial

Catherine Henderson, Martin Knapp, Susan Stirling, Lee Shepstone, Juliet High, Clive Ballard, Peter Bentham, Alistair Burns, Nicolas Farina, Chris Fox, Julia Fountain, Paul Francis, Robert Howard, Iracema Leroi, Gill Livingston, Ramin Nilforooshan, Shirley Nurock, John T. O’Brien, Annabel Price, Ann Marie SwartNaji Tabet, Tanya Telling, Alan J. Thomas, Sube Banerjee

Norwich Medical School
Epidemiology and Public Health
Norwich Clinical Trials Unit
Norwich Epidemiology Centre
Health Services and Primary Care
Cardiovascular and Metabolic Health
Population Health
Statistics

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

33 Downloads (Pure)

1 results

Finished

HTA-SYMBAD – StudY of Mirtazapine or carBamazepine for Agitation in Dementia
Banerjee, S., Fox, C., Shepstone, L., Swart, A. M., Colles, A., High, J., Hojas Garcia, E., Kitchman, L., Pond, M., Shepstone, L., Stirling, S. & Swart, A. M.
National Institute for Health and Care Research
1/12/15 → 31/12/21
Project: Research

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: Findings from a randomized controlled trial

Projects

Search results

HTA-SYMBAD – StudY of Mirtazapine or carBamazepine for Agitation in Dementia